Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

BCMA and CD3 bispecific T cell engaging antibody constructs

US Patent 11352433 · Granted Jun 7, 2022

Estimated economic value: $374,391,000

Assignee

Inventors

View full patent text on Google Patents →